NEW YORK, NY / ACCESSWIRE / October 20, 2022 / Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
- Pzena Investment Management, Inc. (NYSE:PZN), relating to its proposed merger with Pzena Investment Management, LLC. Under the terms of the merger, PZN shareholders are expected to receive $9.60 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/pzena-investment-management-inc. It is free and there is no cost or obligation to you.
- Silverback Therapeutics, Inc. (NASDAQ:SBTX), relating to its proposed merger with ARS Pharmaceuticals, Inc. Under the terms of the agreement, SBTX equity holders are expected to own approximately 37% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/silverback-therapeutics-inc. It is free and there is no cost or obligation to you.
- Cowen Inc. (NASDAQ:COWN), relating to its proposed acquisition by TD Bank Group. Under the terms of the merger, COWN shareholders are expected to receive $39.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/cowen-inc. It is free and there is no cost or obligation to you.
- Orthofix Medical Inc. (NASDAQ:OFIX), relating to its proposed acquisition by SeaSpine Holdings Corp. Under the terms of the agreement, OFIX shareholders are expected to receive 0.4163 shares of SeaSpine per share they own. Click here for more information: https://www.monteverdelaw.com/case/orthofix-medical-inc. It is free and there is no cost or obligation to you.
- IMARA Inc. (NASDAQ:IMRA), relating to its proposed merger with Enliven Therapeutics, Inc. Under the terms of the agreement, IMRA shareholders are expected to own approximately 16% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/imara-inc. It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers in 2013 and 2017-2019 as a Rising Star and in 2022 as a Super Lawyer in Securities Litigation. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, we have recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
SOURCE: Monteverde & Associates PC